Engineering strategies to mimic the glioblastoma microenvironment

作者: Andrew Rape , Badriprasad Ananthanarayanan , Sanjay Kumar

DOI: 10.1016/J.ADDR.2014.08.012

关键词:

摘要: Glioblastoma multiforme (GBM) is the most common and deadly brain tumor, with a mean survival time of only 21months. Despite dramatic improvements in our understanding GBM fueled by recent revolutions molecular systems biology, treatment advances for have progressed inadequately slowly, which due part to wide cellular heterogeneity both across tumors within single tumor. Thus, there increasing clinical interest targeting cell-extrinsic factors as way slowing or halting progression GBM. These factors, collectively termed microenvironment, include extracellular matrix, blood vessels, stromal cells that surround tumor cells, all associated soluble scaffold-bound signals. In this review, we will first describe regulation these microenvironmental factors. Next, discuss various vitro approaches been exploited recapitulate model microenvironment vitro. We conclude identifying future challenges opportunities field, including development platforms amenable high-throughput discovery screening. anticipate ongoing efforts prove be valuable enabling tools accelerating foundations next-generation screening may serve conceptual bridge between traditional reductionist animal studies.

参考文章(191)
C Altaner, Glioblastoma and stem cells. Neoplasma. ,vol. 55, pp. 369- 374 ,(2008)
D Schuppan, W Paulus, I Baur, W Roggendorf, Characterization of integrin receptors in normal and neoplastic human brain. American Journal of Pathology. ,vol. 143, pp. 154- 163 ,(1993)
Kandice R Johnson, Jennifer L Leight, Valerie M Weaver, None, Demystifying the Effects of a Three‐Dimensional Microenvironment in Tissue Morphogenesis Methods in Cell Biology. ,vol. 83, pp. 547- 583 ,(2007) , 10.1016/S0091-679X(07)83023-8
H. J. Scherer, Structural Development in Gliomas American Journal of Cancer. ,vol. 34, pp. 333- 351 ,(1938) , 10.1158/AJC.1938.333
Hirokazu Kaji, Gulden Camci-Unal, Robert Langer, Ali Khademhosseini, Engineering systems for the generation of patterned co-cultures for controlling cell–cell interactions Biochimica et Biophysica Acta (BBA) - General Subjects. ,vol. 1810, pp. 239- 250 ,(2011) , 10.1016/J.BBAGEN.2010.07.002
Duc M. Le, Arnaud Besson, Darrin K. Fogg, Kyu-Sil Choi, David M. Waisman, Cynthia G. Goodyer, Barry Rewcastle, V. Wee Yong, Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade The Journal of Neuroscience. ,vol. 23, pp. 4034- 4043 ,(2003) , 10.1523/JNEUROSCI.23-10-04034.2003
Lance A. Liotta, Garth L. Nicolson, Raymond Sawaya, Gregory N. Fuller, Ziya L. Gokaslan, Hiroshi Sato, Motoharu Seiki, Jasti S. Rao, Sanjeeva Mohanam, Masaaki Yamamoto, Differential Expression of Membrane-Type Matrix Metalloproteinase and Its Correlation with Gelatinase A Activation in Human Malignant Brain Tumors in Vivo and in Vitro Cancer Research. ,vol. 56, pp. 384- 392 ,(1996)
Takanori Ohnishi, Shoju Hiraga, Shuichi Izumoto, Hirotaka Matsumura, Yonehiro Kanemura, Norio Arita, Toru Hayakawa, Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clinical & Experimental Metastasis. ,vol. 16, pp. 729- 741 ,(1998) , 10.1023/A:1006532812408
Shugang Ge, Steve Dudas, Jorge A. Gutiérrez, Sandra A. Rempel, Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma Clinical Cancer Research. ,vol. 6, pp. 102- 111 ,(2000)
Ashwatha Narayana, Deborah Gruber, Saroj Kunnakkat, John G. Golfinos, Erik Parker, Shahzad Raza, David Zagzag, Patricia Eagan, Michael L. Gruber, A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. Journal of Neurosurgery. ,vol. 116, pp. 341- 345 ,(2012) , 10.3171/2011.9.JNS11656